CarthroniX Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
CarthroniX is a biopharmaceutical company based in Los Angeles, California, focused on developing small molecule therapies for cartilage diseases, such as arthritis. Its work aims to preserve, repair, and regenerate cartilage in joints while concurrently reducing inflammation, addressing a combination of degenerative joint conditions and inflammatory processes. The company positions itself within biotechnology research by pursuing novel approaches inspired by work conducted at renowned institutions, and it serves customers who seek treatments targeting cartilage health and joint inflammation. With a small, specialized team, CarthroniX operates in the biopharmaceutical landscape as a research-driven entity focused on advancing therapies for joint-related disorders.